289 related articles for article (PubMed ID: 21376411)
21. Role of platelet-derived growth factor-BB (PDGF-BB) in human pulmonary artery smooth muscle cell proliferation.
Zhao Y; Lv W; Piao H; Chu X; Wang H
J Recept Signal Transduct Res; 2014 Aug; 34(4):254-60. PubMed ID: 24804810
[TBL] [Abstract][Full Text] [Related]
22. Mibefradil suppresses the proliferation of pulmonary artery smooth muscle cells.
Li HH; Xie LJ; Xiao TT; Huang M; Shen J
J Investig Med; 2016 Jan; 64(1):45-9. PubMed ID: 26755813
[TBL] [Abstract][Full Text] [Related]
23. T-type Ca
Sankhe S; Manousakidi S; Antigny F; Arthur Ataam J; Bentebbal S; Ruchon Y; Lecerf F; Sabourin J; Price L; Fadel E; Dorfmüller P; Eddahibi S; Humbert M; Perros F; Capuano V
Biochim Biophys Acta Mol Cell Res; 2017 Oct; 1864(10):1631-1641. PubMed ID: 28655554
[TBL] [Abstract][Full Text] [Related]
24. Sodium butyrate inhibits platelet-derived growth factor-induced proliferation and migration in pulmonary artery smooth muscle cells through Akt inhibition.
Cantoni S; Galletti M; Zambelli F; Valente S; Ponti F; Tassinari R; Pasquinelli G; Galiè N; Ventura C
FEBS J; 2013 May; 280(9):2042-55. PubMed ID: 23463962
[TBL] [Abstract][Full Text] [Related]
25. Multi-omics analysis reveals regulators of the response to PDGF-BB treatment in pulmonary artery smooth muscle cells.
Chen J; Cui X; Qian Z; Li Y; Kang K; Qu J; Li L; Gou D
BMC Genomics; 2016 Oct; 17(1):781. PubMed ID: 27716141
[TBL] [Abstract][Full Text] [Related]
26. Delivery of imatinib-incorporated nanoparticles into lungs suppresses the development of monocrotaline-induced pulmonary arterial hypertension.
Akagi S; Nakamura K; Miura D; Saito Y; Matsubara H; Ogawa A; Matoba T; Egashira K; Ito H
Int Heart J; 2015 May; 56(3):354-9. PubMed ID: 25902888
[TBL] [Abstract][Full Text] [Related]
27. Iptakalim induces mitochondria-dependent apoptosis in hypoxic rat pulmonary arterial smooth muscle cells.
Xu Q; Wu X; Li Y; Kong H; Jin Y; Xie W; Wang H
Biomed Pharmacother; 2016 Dec; 84():773-779. PubMed ID: 27718461
[TBL] [Abstract][Full Text] [Related]
28. Imatinib attenuates monocrotaline pulmonary hypertension and has potent vasodilator activity in pulmonary and systemic vascular beds in the rat.
Pankey EA; Thammasiboon S; Lasker GF; Baber S; Lasky JA; Kadowitz PJ
Am J Physiol Heart Circ Physiol; 2013 Nov; 305(9):H1288-96. PubMed ID: 23997103
[TBL] [Abstract][Full Text] [Related]
29. Calcilytics enhance sildenafil-induced antiproliferation in idiopathic pulmonary arterial hypertension.
Yamamura A; Yagi S; Ohara N; Tsukamoto K
Eur J Pharmacol; 2016 Aug; 784():15-21. PubMed ID: 27164419
[TBL] [Abstract][Full Text] [Related]
30. Rapamycin reverses pulmonary artery smooth muscle cell proliferation in pulmonary hypertension.
Houssaini A; Abid S; Mouraret N; Wan F; Rideau D; Saker M; Marcos E; Tissot CM; Dubois-Randé JL; Amsellem V; Adnot S
Am J Respir Cell Mol Biol; 2013 May; 48(5):568-77. PubMed ID: 23470622
[TBL] [Abstract][Full Text] [Related]
31. Imatinib mesylate has the potential to exert its efficacy by down-regulating the plasma concentration of platelet-derived growth factor in patients with pulmonary arterial hypertension.
Hatano M; Yao A; Shiga T; Kinugawa K; Hirata Y; Nagai R
Int Heart J; 2010 Jul; 51(4):272-6. PubMed ID: 20716845
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of Excessive Cell Proliferation by Calcilytics in Idiopathic Pulmonary Arterial Hypertension.
Yamamura A; Ohara N; Tsukamoto K
PLoS One; 2015; 10(9):e0138384. PubMed ID: 26375676
[TBL] [Abstract][Full Text] [Related]
33. Regulatory effects of Prohibitin 1 on proliferation and apoptosis of pulmonary arterial smooth muscle cells in monocrotaline-induced PAH rats.
Cao YY; Ba HX; Li Y; Tang SY; Luo ZQ; Li XH
Life Sci; 2020 Jun; 250():117548. PubMed ID: 32173312
[TBL] [Abstract][Full Text] [Related]
34. Differential effects of imatinib on PDGF-induced proliferation and PDGF receptor signaling in human arterial and venous smooth muscle cells.
Li L; Blumenthal DK; Masaki T; Terry CM; Cheung AK
J Cell Biochem; 2006 Dec; 99(6):1553-63. PubMed ID: 16817200
[TBL] [Abstract][Full Text] [Related]
35. PDGF-dependent β-catenin activation is associated with abnormal pulmonary artery smooth muscle cell proliferation in pulmonary arterial hypertension.
Takahashi J; Orcholski M; Yuan K; de Jesus Perez V
FEBS Lett; 2016 Jan; 590(1):101-9. PubMed ID: 26787464
[TBL] [Abstract][Full Text] [Related]
36. Bosentan inhibits transient receptor potential channel expression in pulmonary vascular myocytes.
Kunichika N; Landsberg JW; Yu Y; Kunichika H; Thistlethwaite PA; Rubin LJ; Yuan JX
Am J Respir Crit Care Med; 2004 Nov; 170(10):1101-7. PubMed ID: 15317671
[TBL] [Abstract][Full Text] [Related]
37. Imatinib mesylate inhibits the proliferation-stimulating effect of human lung cancer-associated stromal fibroblasts on lung cancer cells.
Kinoshita K; Nakagawa K; Hamada J; Hida Y; Tada M; Kondo S; Moriuchi T
Int J Oncol; 2010 Oct; 37(4):869-77. PubMed ID: 20811709
[TBL] [Abstract][Full Text] [Related]
38. Carvedilol inhibits proliferation of cultured pulmonary artery smooth muscle cells of patients with idiopathic pulmonary arterial hypertension.
Fujio H; Nakamura K; Matsubara H; Kusano KF; Miyaji K; Nagase S; Ikeda T; Ogawa A; Ohta-Ogo K; Miura D; Miura A; Miyazaki M; Date H; Ohe T
J Cardiovasc Pharmacol; 2006 Feb; 47(2):250-5. PubMed ID: 16495763
[TBL] [Abstract][Full Text] [Related]
39. Concurrent rho-kinase and tyrosine kinase platelet-derived growth factor inhibition in experimental pulmonary hypertension.
Jasińska-Stroschein M; Owczarek J; Plichta P; Orszulak-Michalak D
Pharmacology; 2014; 93(3-4):145-50. PubMed ID: 24662671
[TBL] [Abstract][Full Text] [Related]
40. Imatinib induces apoptosis by inhibiting PDGF- but not insulin-induced PI 3-kinase/Akt survival signaling in RGC-5 retinal ganglion cells.
Biswas SK; Zhao Y; Sandirasegarane L
Mol Vis; 2009 Aug; 15():1599-610. PubMed ID: 19693287
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
